Eligibility Pre-hypertension NCT01568983

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
pre-hypertension or hypertension systolic blood pressure in the 130-179 mmhg range and/or diastolic blood pressure in the 85-109 mmhg range)
Descrição

ID.1

Tipo de dados

boolean

bmi 20-35 kg/m2
Descrição

ID.2

Tipo de dados

boolean

stable weight (change <4 kg previous 12 weeks)
Descrição

ID.3

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
regular use of blood pressure lowering agens
Descrição

ID.4

Tipo de dados

boolean

diabetes type i or ii
Descrição

ID.5

Tipo de dados

boolean

smokers
Descrição

ID.6

Tipo de dados

boolean

allergy to grape, cherries, blueberries/bilberries, black currant, aronia
Descrição

ID.7

Tipo de dados

boolean

supplements for weight loss
Descrição

ID.8

Tipo de dados

boolean

changes in pharmacological treatment of hyperlipidemia or hyperglycemia (initiation, termination or changes in dosage) last 30 days prior to inclusion or during the study period (run-in and intervention)
Descrição

ID.9

Tipo de dados

boolean

participation in a drug trial during the previous 30 days
Descrição

ID.10

Tipo de dados

boolean

Similar models

Eligibility Pre-hypertension NCT01568983

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
pre-hypertension or hypertension systolic blood pressure in the 130-179 mmhg range and/or diastolic blood pressure in the 85-109 mmhg range)
boolean
ID.2
Item
bmi 20-35 kg/m2
boolean
ID.3
Item
stable weight (change <4 kg previous 12 weeks)
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
regular use of blood pressure lowering agens
boolean
ID.5
Item
diabetes type i or ii
boolean
ID.6
Item
smokers
boolean
ID.7
Item
allergy to grape, cherries, blueberries/bilberries, black currant, aronia
boolean
ID.8
Item
supplements for weight loss
boolean
ID.9
Item
changes in pharmacological treatment of hyperlipidemia or hyperglycemia (initiation, termination or changes in dosage) last 30 days prior to inclusion or during the study period (run-in and intervention)
boolean
ID.10
Item
participation in a drug trial during the previous 30 days
boolean